TY - JOUR T1 - Accuracy and performance of the WHO 2015 and WHO 2019 HIV testing strategies across epidemic settings JF - medRxiv DO - 10.1101/2021.03.31.21254700 SP - 2021.03.31.21254700 AU - Jeffrey W Eaton AU - Anita Sands AU - Magdalena Barr-DiChiara AU - Muhammad S Jamil AU - Rachel Baggaley AU - Beth A Tippett Barr AU - Thokozani Kalua AU - Andreas Jahn AU - Mathieu Maheu-Giroux AU - Cheryl C Johnson Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254700.abstract N2 - Background WHO 2019 HIV testing guidelines recommended a standard HIV testing strategy consisting of three consecutively HIV-reactive test results on serology assays to diagnose HIV infection. National HIV programmes in high prevalence settings currently using the strategy consisting of only two consecutive HIV-reactive tests should consider when to implement the new guideline recommendations.Methods and Findings We implemented a probability model to simulate outcomes of WHO 2019 and the two strategies recommended by WHO 2015 guidelines on HIV testing services. Each assay in the strategy was assumed independently 99% sensitivity and 98% specificity, the minimal thresholds required for WHO prequalification. For each strategy and positivity ranging 20% to 0.2%, we calculated the number of false-negative, false-positive, and inconclusive results; positive and negative predictive value (PPV, NPV); number of each assay used, and testing programme costs. We found that the NPV was above 99.9% for all scenarios modelled. Under the WHO 2015 two-test strategy, the PPV was below the 99% target threshold when positivity fell below 5%. For the WHO 2019 strategy, the PPV was above 99% for all positivity levels. The number reported ‘inconclusive’ was higher under the WHO 2019 strategy. Implementing the WHO 2019 testing strategy in Malawi, would require around 89,000 A3 tests in 2021, compared to 175,000 A2 tests and over 4.5 million A1 tests per year. The incremental cost of the WHO 2019 strategy was less than 2% in 2021 and declined to 0.9% in 2025.Conclusions As positivity among persons testing for HIV reduces below 5% in nearly all settings, implementation of the WHO 2019 testing strategy will ensure that positive predictive value remains above the 99% target threshold, averting misdiagnoses and ART initiations among HIV uninfected people. The incremental cost of implementing the WHO 2019 HIV testing strategy compared to the two-test strategy is negligible because the third assay accounts for a small and diminishing share of total HIV tests.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJWE was supported by the World Health Organization (https://www.who.int/) and the Bill and Melinda Gates Foundation (OPP1190661; https://www.gatesfoundation.org). CCJ was supported by the United States Agency for International Development (GHA-G-00-09-00003; https://www.usaid.gov) and the Bill and Melinda Gates Foundation (OPP1177903; https://www.gatesfoundation.org).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe national Spectrum file for Malawi are available upon request from UNAIDS: https://www.unaids.org/en/dataanalysis/datatools/spectrum-epp https://www.unaids.org/en/dataanalysis/datatools/spectrum-epp ER -